DFO
CELG

Duquesne Family Office’s Celgene Corp CELG Stock Holding History

Duquesne Family Office’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-188,100
Closed -$27.4M – 53
2017
Q3 		$27.4M Buy
+188,100
New +$25.6M 1.25% 20
2017
Q2 		– Sell
-82,400
Closed -$10.3M – 57
2017
Q1 		$10.3M Buy
+82,400
New +$9.86M 0.67% 39
2015
Q2 		– Sell
-195,975
Closed -$22.6M – 46
2015
Q1 		$22.6M Sell
195,975
-238,125
-55% -$28.5M 2.87% 13
2014
Q4 		$48.6M Sell
434,100
-126,500
-23% -$13.3M 4.76% 6
2014
Q3 		$53.1M Buy
560,600
+284,600
+103% +$25.7M 6.52% 4
2014
Q2 		$23.7M Buy
+276,000
New +$21M 1.69% 18

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Duquesne Family Office's CELG Position: Q4 2017 in Review

Duquesne Family Office sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 188,100 shares — an estimated $27.4M sold.

Duquesne Family Office first reported a position in CELG in Q2 2014 and held it in 6 quarters. The position peaked at $53.1M in Q3 2014. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Duquesne Family Office reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Duquesne Family Office sold 188,100 Celgene Corp shares in Q4 2017, an estimated $27.4M.
  • Duquesne Family Office first reported a position in Celgene Corp in Q2 2014 and held it in 6 quarters.
  • Duquesne Family Office's Celgene Corp position peaked at $53.1M in Q3 2014.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Duquesne Family Office's 13F filing for Q4 2017, filed 14 Feb 2018.